TGTX icon

TG Therapeutics

115 hedge funds and large institutions have $200M invested in TG Therapeutics in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 43 increasing their positions, 27 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

25% less capital invested

Capital invested by funds: $267M → $200M (-$66.5M)

41% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 27

Holders
115
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.51M
Puts
$2.2M
Net Calls
Net Calls Change

Top Buyers

1 +$6.57M
2 +$4.3M
3 +$2.39M
4
ACA
Avoro Capital Advisors
New York
+$2.25M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.15M

Top Sellers

1 -$10.6M
2 -$4.42M
3 -$2.49M
4
Bank of America
Bank of America
North Carolina
-$2.39M
5
EU
Emory University
Georgia
-$1.3M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$229K
52
$211K
53
$210K
54
$205K
55
$202K
56
$189K
57
$185K
58
$170K
59
$165K
60
$157K
61
$154K
62
$146K
63
$143K
64
$123K
65
$117K
66
$116K
67
$109K
68
$90K
69
$89K
70
$86K
71
$81.9K
72
$76K
73
$73K
74
$69K
75
$68K